首页|健脾消脂方异病同治2型糖尿病合并脂代谢紊乱的网络药理学机制分析

健脾消脂方异病同治2型糖尿病合并脂代谢紊乱的网络药理学机制分析

扫码查看
目的 探讨健脾消脂方异病同治 2 型糖尿病(T2DM)合并脂代谢紊乱潜在作用机制。方法 通过中药系统药理学分析平台(TCMSP)获得健脾消脂方中主要的活性成分及其潜在靶蛋白。利用GeneCards、OMIM和TTD数据库筛选出与T2DM、脂代谢紊乱相关的疾病靶点,并通过Cytoscape3。7。0 软件构建"成分-靶点-基因-疾病"网络图;将T2DM、脂代谢紊乱的共同靶点导入STRING数据库构建蛋白质互作(PPI)网络图,并将PPI分析数据导入Cytoscape3。7。0 软件中,筛选出健脾消脂方异病同治T2DM合并脂代谢紊乱的核心靶点,并构建核心靶点网络图。在DAVID数据库中进行GO富集分析及KEGG通路富集分析。结果 检索到健脾消脂方 71 种药物活性成分,262 个有效靶点,2 型糖尿病相关靶点 2 078 个、脂代谢紊乱相关靶点 1 467 个,药物与疾病的共同靶点 133 个。GO与KEGG分析表明健脾消脂方治疗T2DM合并脂代谢紊乱主要涉及晚期糖基化终末产物-糖基化终末产物受体(AGE-RAGE)信号通路、肿瘤坏死因子(TNF)信号通路、磷脂酰肌醇-3 激酶/蛋白激酶B(PI3K-AKT)信号通路、缺氧诱导因子-1(HIF-1)信号通路、丝裂原活化蛋白激酶(MAPK)信号通路、白细胞介素-17(IL-17)信号通路等。结论 健脾消脂方异病同治T2DM合并脂代谢紊乱可能是通过AGE-RAGE、TNF、PI3K-AKT、IL-17、HIF-1 等信号通路改善了胰岛素抵抗和炎症反应。
Network pharmacological mechanism analysis of same treatment of different diseases of Jianpi Xiaozhi Fang in treating type 2 diabetes mellitus complicated with lipid metabolism disorder
Objective To explore the potential mechanism of same treatment of different diseases of Jianpi Xiaozhi Fang in treating type 2 diabetes mellitus(T2DM)complicated with lipid metabolism disorder.Methods The main active constituents and their potential target proteins of Jianpi Xiaozhi Fang were obtained by TCMSP.Disease targets associated with T2DM and dyslipidemia were screened using GeneCards,OMIM and TTD databases,and the"composition-target-gene-disease"network map was constructed using Cytoscape3.7.0 software.GO enrichment analysis and KEGG pathway enrichment analysis were conducted in DAVID database.Results 71 effective components of Jianpi Xiaozhi Fang,262 effective targets,2 078 targets for T2DM,1 467 targets associated with lipid metabolism disorder,133 common targets of drugs and diseases were searched.The common target of T2DM and lipid metabolism disorders was imported into the STRING database to build a protein interaction(PPI)network map,and the PPI analysis data was imported into Cytoscape3.7.0 software to screen out the core target of T2DM combined with lipid metabolism disorders,and builded a core target network map.The results of GO and KEGG indicated that the Jianpi Xiaozhi Fang was related to AGE-RAGE,TNF,PI3K-AKT,IL-17 and HIF-1 signaling pathway.Conclusion Same treatment of different diseases of Jianpi Xiaozhi Fang in treating type 2 diabetes mellitus(T2DM)complicated with lipid metabolism disorder may improve insulin resistance and inflammatory response through AGE-RAGE,TNF,PI3K-AKT,HIF-1,IL-17 and other signaling pathways.

Jianpi Xiaozhi FangSame treatment of different diseasesT2DM with lipid metabolism disorderNetwork pharmacologyMechanism of action

朱珠、刘怀珍、常硕

展开 >

安徽中医药大学第一临床医学院,合肥 230031

安徽中医药大学第一附属医院,合肥 230031

健脾消脂方 异病同治 T2DM合并脂代谢紊乱 网络药理学 作用机制

安徽省中医药领军人才建设项目

中医药发展秘[2018]23号

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(2)
  • 31